Skip to content

13F-HR filed by Boxer Capital Management, LLC

Boxer Capital Management, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:30:08 UTC, with 47 holding rows worth $1,150,652,180.

Accession
0001213900-26-120704
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 47 entries on the cover page, a total value of $1,150,652,180 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,150,652,180 with VALUE read as dollars as filed, 13F file number 028-25329. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TANGO THERAPEUTICS INC87583X109COM10,526,219$262,629,164dollars as filed
KODIAK SCIENCES INC50015M109COM1,477,600$140,076,480dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock500,000$102,630,000dollars as filed
KYMERA THERAPEUTICS INC501575104COM524,551$58,639,556dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK4,278,159$56,642,825dollars as filed
ABIVAX SA-00370M103SPONSORED ADS474,971$47,031,628dollars as filed
SURROZEN INC86889P208COMMON STOCK1,360,683$43,786,778dollars as filed
CORCEPT THERAPEUTICS INC218352102COM335,500$38,659,665dollars as filed
PRECIGEN INC74017N105COM4,320,339$36,982,101dollars as filed
UNIQURE NVN90064101SHS1,423,243$34,385,550dollars as filed
DEFINIUM THERAPEUTICS INC24477V105COM SHS683,615$26,018,386dollars as filed
AMYLYX PHARMACEUTICALS INC03237H101COM893,153$25,990,752dollars as filed
SPYRE THERAPEUTICS INC00773J202COM NEW283,054$25,200,297dollars as filed
PROTAGONIST THERAPEUTICS74366E102COM170,000$23,951,300dollars as filed
CELCUITY INC15102K100COM286,239$22,761,725dollars as filed
OPUS GENETICS INC67577R102COMMON STOCK4,533,660$21,942,914dollars as filed
Q32 BIO INC746964105Common Stock2,577,642$21,317,099dollars as filed
UROGEN PHARMA LTDM96088105COMMON STOCK500,000$20,315,000dollars as filed
ACHIEVE LIFE SCIENCES INC004468500COMMON STOCK2,150,000$17,393,500dollars as filed
C4 THERAPEUTICS INC12529R107COM STK4,150,000$13,819,500dollars as filed
FIRST TRACKS BIOTHERAPEUTICS337185102ORD SHS *A*240,000$8,505,600dollars as filed
SHATTUCK LABS INC82024L103COMMON STOCK1,175,396$8,016,200dollars as filed
SAB BIOTHERAPEUTICS INC78397T202COMMON STOCK2,500,000$7,925,000dollars as filed
CULLINAN THERAPEUTICS INC230031106COM450,000$6,907,500dollars as filed
CONTINEUM THERAPEUTICS INC CL A21217B100Stock494,000$6,629,480dollars as filed
CYTOKINETICS INC23282W605COM NEW100,000$6,591,000dollars as filed
PALISADE BIO INC696389402COMMON STOCK4,799,875$6,479,831dollars as filed
CAPRICOR THERAPEUTICS INC14070B309COMMON STOCK642,837$6,087,666dollars as filed
Electra Therapeutics, Inc.284825106Common Stock, $0.0001 par value per share450,000$5,062,500dollars as filed
AN2 THERAPEUTICS INC037326105COM944,035$5,022,266dollars as filed
MAZE THERAPEUTICS INC COM578784100Stock175,465$4,769,138dollars as filed
EDESA BIOTECH INC27966L306COM NEW937,363$3,946,298dollars as filed
RELAY THERAPEUTICS INC COM75943R102Stock200,000$3,610,000dollars as filed
KAZIA THERAPEUTICS LTD48669G303SPONSORED ADS371,500$3,564,542dollars as filed
ATTOVIA THERAPEUTICS INC04987L102COM200,000$3,428,000dollars as filed
PMV PHARMACEUTICALS INC69353Y103COM2,050,000$3,423,500dollars as filed
CRESCENT BIOPHARMA INC.38000Q201COM226,843$3,309,639dollars as filed
ZENTALIS PHARMACEUTICALS INC98943L107COMMON STOCK1,013,555$2,807,547dollars as filed
SAREPTA THERAPEUTICS INC803607100COM150,000$2,733,000dollars as filed
ALLOGENE THERAPEUTICS INC019770106COM1,500,000$2,400,000dollars as filed
NURIX THERAPEUTICS INC67080M103COMMON STOCK100,000$2,371,000dollars as filed
SIONNA THERAPEUTICS INC829401108COMMON STOCK391,723$2,060,462dollars as filed
CLENE INC185634201COM NEW477,515$1,948,261dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock300,000$1,578,000dollars as filed
Milestone Pharmaceuticals Inc59935V107COM666,666$577,132dollars as filed
NEUMORA THERAPEUTICS INC.640979100COM954,052$568,805dollars as filed
KARYOPHARM THERAPEUTICS INC48576U205COMMON STOCK127,536$155,593dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001213900-26-120704this filing2026-11-16